Literature DB >> 24882906

Severity of obstructive sleep apnea is associated with cardiac troponin I concentrations in a community-based sample: data from the Akershus Sleep Apnea Project.

Gunnar Einvik1, Helge Røsjø1, Anna Randby1, Silje K Namtvedt1, Harald Hrubos-Strøm2, Jon Brynildsen1, Virend K Somers3, Torbjørn Omland1.   

Abstract

OBJECTIVES: Previous community-based studies have failed to demonstrate an independent association between OSA and circulating cardiac troponin concentrations, a marker of myocardial injury. However, these studies have used troponin assays with modest analytic sensitivity to detect low-level, chronic increments in troponin levels. Using a highly sensitive troponin I (hs-TnI) assay, we tested the hypothesis that the severity of OSA is associated with myocardial injury independently of comorbidities.
DESIGN: Cross-sectional study.
SETTING: Community-based. PARTICIPANTS: 514 subjects (54% men, age 48 ± 11 y [mean ± SD]).
INTERVENTIONS: N/A. MEASUREMENTS AND
RESULTS: hs-TnI concentrations were measured in fasting morning blood samples and 318 participants (62%) had hs-TnI concentration above the limit of detection ([LoD] 1.2 ng/L). The severity of OSA, expressed as the apnea-hypopnea index (AHI) and nocturnal hypoxemia, was assessed by in-hospital polysomnography. After adjustment for age, gender, estimated creatinine clearance, history of coronary artery disease and hypertension, smoking, diabetes mellitus, systolic blood pressure, heart rate, body mass index, left ventricular hypertrophy, and cholesterol ratio in multivariate linear regression models, higher AHI (standardized β = 0.12, P = 0.006), lower mean SpO2 (β = -0.13, P = 0.012) and higher percentage of total sleep time with SpO2 < 90% (β = 0.12, P = 0.011) were all associated with higher hs-TnI levels in separate models. Additional analyses with hs-TnI categorized in tertiles or using a different strategy for persons with hs-TnI levels below the LoD did not change the results.
CONCLUSION: Increased obstructive sleep apnea (OSA) severity is independently associated with higher concentrations of hs-TnI, suggesting that frequent apneas or hypoxemia in OSA may cause low-grade myocardial injury.

Entities:  

Keywords:  Akershus Sleep Apnea Project; obstructive sleep apnea; polysomnography; troponin I

Mesh:

Substances:

Year:  2014        PMID: 24882906      PMCID: PMC4015385          DOI: 10.5665/sleep.3772

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  34 in total

Review 1.  Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications.

Authors:  Takatoshi Kasai; T Douglas Bradley
Journal:  J Am Coll Cardiol       Date:  2011-01-11       Impact factor: 24.094

Review 2.  Metabolic disorders associated with obstructive sleep apnea in adults.

Authors: 
Journal:  Adv Cardiol       Date:  2011-10-13

Review 3.  Cardiovascular disorders associated with obstructive sleep apnea.

Authors: 
Journal:  Adv Cardiol       Date:  2011-10-13

4.  Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis?

Authors:  Harvey D White
Journal:  J Am Coll Cardiol       Date:  2011-06-14       Impact factor: 24.094

5.  Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study.

Authors:  Aslan T Turer; Tayo A Addo; Justin L Martin; Marc S Sabatine; Gregory D Lewis; Robert E Gerszten; Ellen C Keeley; Joaquin E Cigarroa; Richard A Lange; L David Hillis; James A de Lemos
Journal:  J Am Coll Cardiol       Date:  2011-06-14       Impact factor: 24.094

6.  Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T.

Authors:  Allan S Jaffe; Vlad C Vasile; Margherita Milone; Amy K Saenger; Kalen N Olson; Fred S Apple
Journal:  J Am Coll Cardiol       Date:  2011-09-29       Impact factor: 24.094

7.  A Norwegian population-based study on the risk and prevalence of obstructive sleep apnea. The Akershus Sleep Apnea Project (ASAP).

Authors:  Harald Hrubos-Strøm; Anna Randby; Silje K Namtvedt; Håvard A Kristiansen; Gunnar Einvik; Jūratėšaltytė Benth; Virend K Somers; Inger H Nordhus; Michael B Russell; Toril Dammen; Torbjørn Omland; Kari J Kværner
Journal:  J Sleep Res       Date:  2011-03       Impact factor: 3.981

8.  Left ventricular diastolic dysfunction is linked to severity of obstructive sleep apnoea.

Authors:  J-P Baguet; G Barone-Rochette; P Lévy; E Vautrin; H Pierre; O Ormezzano; J-L Pépin
Journal:  Eur Respir J       Date:  2010-06-18       Impact factor: 16.671

Review 9.  Obstructive sleep apnea and the risk for cardiovascular disease.

Authors:  Puja Kohli; Jay S Balachandran; Atul Malhotra
Journal:  Curr Atheroscler Rep       Date:  2011-04       Impact factor: 5.113

10.  Impact of CPAP treatment on cardiac biomarkers and pro-BNP in obstructive sleep apnea syndrome.

Authors:  Nilüfer Cifçi; Meral Uyar; Osman Elbek; Hüseyin Süyür; Erhan Ekinci
Journal:  Sleep Breath       Date:  2009-10-08       Impact factor: 2.816

View more
  19 in total

1.  Sex-Specific Association of Sleep Apnea Severity With Subclinical Myocardial Injury, Ventricular Hypertrophy, and Heart Failure Risk in a Community-Dwelling Cohort: The Atherosclerosis Risk in Communities-Sleep Heart Health Study.

Authors:  Gabriela Querejeta Roca; Susan Redline; Brian Claggett; Natalie Bello; Christie M Ballantyne; Scott D Solomon; Amil M Shah
Journal:  Circulation       Date:  2015-08-27       Impact factor: 29.690

2.  Markers of Myocardial Ischemia in Patients With Coronary Artery Disease and Obstructive Sleep Apnea: Effect of Continuous Positive Airway Pressure Therapy.

Authors:  Misa Valo; Annette Wons; Albert Moeller; Claudius Teupe
Journal:  Clin Cardiol       Date:  2015-07-14       Impact factor: 2.882

Review 3.  Biomarkers in Sleep Apnea and Heart Failure.

Authors:  Ying Y Zhao; Reena Mehra
Journal:  Curr Heart Fail Rep       Date:  2017-08

Review 4.  Sleep apnea in total joint arthroplasty patients and the role for cardiac biomarkers for risk stratification: an exploration of feasibility.

Authors:  M Melanie Lyons; Nitin Y Bhatt; Elizabeth Kneeland-Szanto; Brendan T Keenan; Joanne Pechar; Branden Stearns; Nabil M Elkassabany; Stavros G Memtsoudis; Allan I Pack; Indira Gurubhagavatula
Journal:  Biomark Med       Date:  2016       Impact factor: 2.851

5.  The impact of obstructive sleep apnoea severity on cardiac structure and injury.

Authors:  Sandeep Raut; Gaurav Gupta; Rajiv Narang; Animesh Ray; R M Pandey; Atul Malhotra; Sanjeev Sinha
Journal:  Sleep Med       Date:  2020-11-05       Impact factor: 3.492

6.  Effects of sleep apnea hypopnea syndromes on cardiovascular events: a systematic review and meta-analysis.

Authors:  Liang Xie; Penghao Zhen; Fuchao Yu; Xiaojin Yu; Hai Qian; Fang Yang; Jiayi Tong
Journal:  Sleep Breath       Date:  2021-03-26       Impact factor: 2.816

Review 7.  Chronic Kidney Disease and Sleeping Disordered Breathing (SDB).

Authors:  Roberto Sávio Silva Santos; Shveta S Motwani; Rosilene Motta Elias
Journal:  Curr Hypertens Rev       Date:  2016

8.  Stable Breathing in Patients With Obstructive Sleep Apnea Is Associated With Increased Effort but Not Lowered Metabolic Rate.

Authors:  Camila M de Melo; Luigi Taranto-Montemurro; James P Butler; David P White; Stephen H Loring; Ali Azarbarzin; Melania Marques; Philip J Berger; Andrew Wellman; Scott A Sands
Journal:  Sleep       Date:  2017-10-01       Impact factor: 5.849

9.  Untreated Obstructive Sleep Apnea Is Associated With Myocardial Injury Independent of Blood Pressure Control in Hypertension.

Authors:  Macy M S Lui; H F Tse; Judith C W Mak; David C L Lam; Carmen W S Chan; Peony W C Chong; Mary S M Ip
Journal:  J Clin Sleep Med       Date:  2018-11-15       Impact factor: 4.062

10.  Sleep-disordered breathing and left ventricular scar on cardiac magnetic resonance: results of the Multi-Ethnic Study of Atherosclerosis.

Authors:  Neomi A Shah; Michelle Reid; Jorge R Kizer; Ravi K Sharma; Ravi V Shah; Vaishnavi Kundel; Bharath Ambale-Venkatesh; Zahi A Fayad; Steven J Shea; Robert C Kaplan; Joao A C Lima; Susan Redline
Journal:  J Clin Sleep Med       Date:  2020-06-15       Impact factor: 4.324

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.